J. Scheffert

发表

Timing of Factor VIIa in Liver Transplantation Impacts Cost and Clinical Outcomes

K. Chavin, P. Baliga, D. Taber, 2013, Pharmacotherapy.

COVID-19 in lung transplant recipients: A single center case series from New York City

F. D'Ovidio, Marcus R. Pereira, J. Sonett, 2020, American Journal of Transplantation.

SARS‐CoV‐2 infection increases tacrolimus concentrations in solid‐organ transplant recipients

B. Samstein, E. Verna, D. Salerno, 2020, Clinical transplantation.

Less bleeding associated with apixaban versus other direct acting oral anticoagulation in solid organ transplant recipients

D. Salerno, H. Robbins, D. Jennings, 2021, Clinical transplantation.

Immunosuppression in lung transplantation.

K. Raza, J. Scheffert, 2014, Journal of Thoracic Disease.

One Year Into the Pandemic: Evolving COVID-19 Outcomes in Lung Transplant Recipients, a Single-center Experience

F. D'Ovidio, J. Sonett, S. Arcasoy, 2022, Transplantation direct.

Clinical Outcomes Associated With the Early Postoperative Use of Heparin in Pancreas Transplantation

C. Bratton, K. Chavin, P. Baliga, 2014, Transplantation.

Immunosuppression considerations in simultaneous organ transplant

A. Anamisis, D. Salerno, D. Jennings, 2020, Pharmacotherapy.

Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID‐19 in solid organ transplant recipients

D. Salerno, Marcus R. Pereira, D. Jennings, 2022, American Journal of Transplantation.

Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center.

Spencer T. Martin, Shreya A. Shah, D. Tsapepas, 2015, Diagnostic microbiology and infectious disease.

Nirmatrelvir/ritonavir use: Managing clinically significant drug‐drug interactions with transplant immunosuppressants

L. Ratner, D. Salerno, Marcus R. Pereira, 2022, American Journal of Transplantation.

Impact of Omicron on Lung Transplant Recipients: A Third COVID-19 Surge with Different Outcomes

F. D'Ovidio, S. Arcasoy, L. Benvenuto, 2022, Annals of the American Thoracic Society.

Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool

Yuan Zhang, S. Arcasoy, L. Benvenuto, 2022, Transplantation Proceedings.

Managing the significant drug‐drug interaction between tacrolimus and letermovir in solid organ transplant recipients

A. Anamisis, D. Salerno, J. Scheffert, 2021, Clinical transplantation.

Elevated posaconazole trough concentrations are not associated with increased risk for posaconazole toxicity in lung transplant recipients

D. Salerno, J. Scheffert, N. Lange, 2022, Clinical transplantation.

Nitazoxanide treatment for norovirus infection in solid organ transplant recipients

A. Anamisis, D. Salerno, D. Jennings, 2022, Clinical Transplantation.

Immunosuppression in lung transplantation.

K. Raza, J. Scheffert, Jenna L Scheffert, 2014, Journal of thoracic disease.